Single-dose high-dose-rate brachytherapy compared to two and three fractions for locally advanced prostate cancer.
CONCLUSIONS: A single dose of 19-20Gy achieves similar rates of late morbidity and biochemical control compared to 2 and 3 fractions.
PMID: 28666552 [PubMed - as supplied by publisher]
Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology - Category: Radiology Authors: Hoskin P, Rojas A, Ostler P, Hughes R, Alonzi R, Lowe G Tags: Radiother Oncol Source Type: research
More News: Brachytherapy | Cancer | Cancer & Oncology | Gastroenterology | Prostate Cancer | Radiology | Study